These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2239477)

  • 21. Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease.
    Sabbagh MN; Lahti T; Connor DJ; Caviness JN; Shill H; Vedders L; Mahant P; Samanta J; Burns RS; Evidente VG; Driver-Dunckley E; Reisberg B; Bircea S; Adler CH
    Dement Geriatr Cogn Disord; 2007; 24(5):327-34. PubMed ID: 17851237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease.
    Arendt T; Brückner MK; Bigl V; Marcova L
    J Comp Neurol; 1995 Jan; 351(2):189-222. PubMed ID: 7535318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
    Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
    Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can we prevent Parkinson's and Alzheimer's disease?
    Kedar NP
    J Postgrad Med; 2003; 49(3):236-45. PubMed ID: 14597787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Commonalities in the genetics of Alzheimer's disease and Parkinson's disease.
    Grünblatt E
    Expert Rev Neurother; 2008 Dec; 8(12):1865-77. PubMed ID: 19086884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.
    Mariani E; Polidori MC; Cherubini A; Mecocci P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 827(1):65-75. PubMed ID: 16183338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
    Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
    Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropathological substrates of Alzheimer's disease and Parkinson's disease.
    Jellinger K
    J Neural Transm Suppl; 1987; 24():109-29. PubMed ID: 3316494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of rates of progression in Alzheimer's disease and Parkinson's disease.
    Rosen TJ; Growdon JH; Corkin S
    J Neural Transm Suppl; 1987; 24():105-7. PubMed ID: 3479521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.
    de la Monte SM; Wells SE; Hedley-Whyte T; Growdon JH
    Ann Neurol; 1989 Sep; 26(3):309-20. PubMed ID: 2802531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are dopaminergic neurons selectively vulnerable to Parkinson's disease?
    Agid Y; Ruberg M; Javoy-Agid F; Hirsch E; Raisman-Vozari R; Vyas S; Faucheux B; Michel P; Kastner A; Blanchard V
    Adv Neurol; 1993; 60():148-64. PubMed ID: 8420132
    [No Abstract]   [Full Text] [Related]  

  • 32. Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases.
    Egensperger R; Kösel S; Schnopp NM; Mehraein P; Graeber MB
    Neuropathol Appl Neurobiol; 1997 Aug; 23(4):315-21. PubMed ID: 9292870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease.
    Isobe C; Murata T; Sato C; Terayama Y
    Life Sci; 2005 Aug; 77(15):1836-43. PubMed ID: 15935398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First signs of glaucoma injury occur in the brain. What has generally been considered an eye disease is actually related to conditions such as Alzheimer's and Parkinson's diseases.
    Duke Med Health News; 2010 May; 16(5):4-5. PubMed ID: 20518132
    [No Abstract]   [Full Text] [Related]  

  • 35. Resting-state networks in Alzheimer's disease and Parkinson's disease.
    Rektorova I
    Neurodegener Dis; 2014; 13(2-3):186-8. PubMed ID: 24008996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease.
    Heafield MT; Fearn S; Steventon GB; Waring RH; Williams AC; Sturman SG
    Neurosci Lett; 1990 Mar; 110(1-2):216-20. PubMed ID: 2325885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The hypothesis of motoneuron disease. A proposal for clinical neurology].
    Sica RE; Sanz OP; O'Neill EM; Colombi A
    Medicina (B Aires); 1978; 38(6 Pt 1):717-26. PubMed ID: 750862
    [No Abstract]   [Full Text] [Related]  

  • 38. The disease intersection of susceptibility and exposure: chemical exposures and neurodegenerative disease risk.
    Tanner CM; Goldman SM; Ross GW; Grate SJ
    Alzheimers Dement; 2014 Jun; 10(3 Suppl):S213-25. PubMed ID: 24924672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deciphering the function and regulation of microRNAs in Alzheimer's disease and Parkinson's disease.
    Qiu L; Zhang W; Tan EK; Zeng L
    ACS Chem Neurosci; 2014 Oct; 5(10):884-94. PubMed ID: 25210999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies.
    Fratiglioni L; Wang HX
    Behav Brain Res; 2000 Aug; 113(1-2):117-20. PubMed ID: 10942038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.